LSL.V LSL Pharma Group Inc.

Healthcare Pharmaceuticals TSX Venture Exchange
0.3100 CAD
Close of Nov 7, 2026
0.2600 0.5600
Market cap
CAD 39.3M
P/E
-
P/B
1.79x
ROE
-46.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is LSL.V undervalued?

Graham number

The Graham number of LSL Pharma Group Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LSL Pharma Group Inc. fundamental analysis

No fundamental analysis for LSL Pharma Group Inc. yet.

LSL Pharma Group Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LSL Pharma Group Inc.

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. It offers dietary supplements and vitamins in the tablet and capsule form; niche sterile ophthalmic products in the form of ointments and drops; and cosmetic, pharmaceutical, as well as natural health products in sachets, capsules, loose powder, blister packs, and liquids for pharma…

Full company profile